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Direct Demonstration of Elevated Aldehyde Dehydrogenase in Human Hematopoietic Progenitor Cells
By Michael B. Kastan, Eileen Schlaffer, James-E. Russo, 0. Michael Colvin, Curt 1. Civin, and John Hilton
Relative levels of cytoplasmic aldehyde dehydrogenase (ALDH) were determined in selected subpopulations of normal human bone marrow cells using a flow cytometric assay that simultaneously detects a cell surface antigen (as a marker of cell lineage and developmental stage) and the level of ALDH. The intracellular level of this enzyme has been shown to be directly related to cellular resistance to activated cyclophosphamide and is believed to be important in the survival of cells capable of repopulating marrow in autologous bone marrow transplant procedures. Western blot analysis and flow cytometric analysis of four murine cell lines with known ALDH levels were used to HE UNIQUE POSITION of activated cyclophospha-T mide (4-hydroperoxycyclophosphamide) in purging regimens for autologous bone marrow transplant appears to be based on the ability of this alkylating agent to selectively spare immature hematopoietic cells capable of repopulating the transplant recipient rendered aplastic by high-dose chemotherapy and/or total body irradiation.' The physiologic basis for the relative resistance of lymphohematopoietic progenitor cells to activated cyclophosphamide was the subject of our investigation.
A number of studies have indicated that resistance to cyclophosphamide is determined by the activity levels of cellular aldehyde dehydrogenase (ALDH).233 The cytoplasmic ALDH isozyme, which has a low Michaelis constant (K,) for aldophosphamide; is the enzyme responsible for the conversion of activated cyclophosphamide to the inactive excretory product, carboxyphosphamide, in both murine and human cell line^.^.^.^ A role for the ALDH enzyme in causing cyclophosphamide resistance in murine tumors,' intestinal crypt^,^ and marrow,' and in human hematopoietic blast cells in cultureg has been shown indirectly by measurement of the toxicity of 4-hydroperoxycyclophosphamide in the presence of inhibitors of cytoplasmic ALDH.
This report describes the measurement of cytoplasmic aldehyde dehydrogenase using affinity purified polyclonal antibodies to murine and human ALDH and flow cytometric analysis. This approach allows direct measurement of relative ALDH levels in selected lymphohematopoietic cell subpopulations. Our results indicate that the most primitive hematopoietic cells contain relatively high levels of ALDH that potentially protect these cells against activated cyclophosphamide in tumor cell purging regimen and in vivo.
METHODS
Murine cell lines L1210/0, L1210/ CPA, 41 6-B, and RL-12, and human leukemia HL-60 were cultured in RPMI 1640 medium containing 10% fetal bovine serum and 50 pmol/L 2-mercaptoethanol. Cell The methods for production and characterization of polyclonal antibodies from rabbits has been described? The rabbit anti-mouse ALDH was raised against purified mouse cytoplasmic ALDH from L12IO/CPA cells. For the production of the antihuman ALDH, rabbits were challenged with cytoplasmic ALDH purified from Hep G2 hepatoma. Both antibodies were affinity purified using a column containing purified mouse ALDH attached to Sepharose 4B. For control studies, an enriched IgG fraction, prepared by passing pre-immune serum over a column of CM Affi-Gel Blue Support (Bio-Rad, Richmond, CA), was used at an IgG concentration similar to that of the affinity purified antibodies. Antibodies directed against hematopoietic cell surface antigens and phycoerythrin (PE) conjugates were obtained and used as described.",'2 Affinity purified, fluorescein isothiwyanate (FITC)-conjugated goat anti-rabbit IgG was obtained from Caltag (San Francisco, CA). For personal at PENN STATE UNIVERSITY on February 20, 2013. bloodjournal.hematologylibrary.org From Wcsrcrn !doffing. Methods previously described were used for Western blotting.' "'I-labeled protein A was used to detect the ALDH separated by sodium dodecyl sulfate-polyacrylamide gel electrophorais (SDS-PAGE) and electrotransfcred to n i t r a l l u -
IW.
F / m cyromcrry. Cell surface antigen and intracellular protein fluorescence labeling was done as described previously."," except that 0.02% Triton X-100 was used for prmeabiliistion and wash steps. All procedures were carried out at 4"C. Briefly. cell surface antigens were labeled directly or indirectly with PE-oonjugated antibodies. (It was not necasary to perform cell surface labeling in the evaluation of ALDH in the leukemia cell lines.) The cells were fixed in 15% paraformaldehyde in phosphate-buffd saline and prmeabilited with 0.02% Triton X-100 in IFA buffer (IO mmol/L MEPFS. pH 7.4. I50 mmol/L YaCI. 4% newborn calf s a " . 0.01% NaS,). The permeabliied cells were incubated with 0.1 mL of rabbit anti-mousc ALDH (1:400 in IFA buffer). rabbit anti-human ALDH (1:100 in IFA buffer). or control rabbit lgG for 1 hour followed by incubation with FlTC-conjugated goat anti-rabbit IgG (1:100 to 1:300 in IFA buffer). Goat serum ( 2 7 ) and human AH+ serum (2%) were present as nonspecific blocking sera during each antibody incubation.
RESULTS
A Row cytometric assay was rmntly developed that permits simultaneous identification of a cell surface antigen delineating lymphohematopoietic cell lineage and/or maturation stage and relative quantitation of an intracellular protein."." After labeling the cell surface with lineage-and maturation stage-specific PE-conjugated antibodies. the cells are fixed with paraformaldehyde. permeabilized with detergent and labeled (in one or two steps) with FITC-conjugated antibodies directed against intracellular proteins. Thus. relative levels of an intracellular protein of interest can be evaluated in selected populations of normal hematopoietic cells without cumbersome cell isolation procedures. This assay was originally developed for characterizing relative levels of intranuclear proteins in several hematopoietic cell populations.".'? Cytoplasmic proteins can be similarly analyzed. except that a lower detergent concentration than that used for nuclear proteins is optimal for permeabili7ation.
We used previously characterized. affinity-purified polyclonal antibodies to murine ALDH' and several mouse leukemia cell lines that had been already characterized in terms of ALDH levels to adapt the flow cytometric assay for ALDH measurements. lmmunoblors using this antibody revealed detectable levels of ALDH in the cyclophosphamideresistant cell lines L1210/CPA and 416-R. but not in the cyclophosphamide-sensitive lines Ll2lO/O and RLI2 ( Fig  I) . In agreement with the immunoblots. the flow cytometric assay confirmed easily detectable levels of ALDH with this antibody relative to the control antibodies in LIZIOICPA and 41 6-R. while the cyclophosphamide-sensitive cell lines appeared to have very low levels of ALDH (Fig 2) . This demonstrates that the use of this antibody in the flow cytometric assay accurately reflects ALDH levels in hematopoietic cells.
This approach was t hen used to characterize relative levels of ALDH in selected normal human hematopoietic cell populations. The plyclonal antibody recognizing human ALDH was afinity purified and then charactcrized by 
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immunoblots of cytosolic extracts of human cell lines (Fig 3) .
Extracts of cells with high ALDH content (human liver and hepatoma Hep G2) gave strong signals (lanes 4 and 5). migrating identically to purified human ALDH (lane 3).
while no signal was evident from extracts of cells that lack cytoplasmic ALDH (HL60 and MCF7. lanes I and 2). Thisanti-human ALDH antibody was then used tocharacterizc relative levels of ALDH in selected normal human hematopoietic cell populations by Row cytometry. The normal human hematopoietic cell populations were identified by PE-labeled cell surface markers (as previously and relative levels of ALDH in each population were evaluated as described above. The progenitor cell population.
identified by the presence of the cell surface marker CD34.
appeared to have the highest amounts of ALDH (Fig 4) . The erythroid progenitor cell population (mature red blood cells do not survive the detergent treatment in the assay), identified by the presence of the glycophorin antigen or the lack of the cell surface marker CD45.'-' was somewhat heterogeneous, but contained a population with relatively high levels of ALDH. Mature lymphoid cells (R and T lineage) and monocytes had lower levcls of ALDH. In order to correct for any possible variability in background binding levels in the various cell populations.'? a "corrected mean fluorescence intensity" was also calculated for each cell population ( Fig  4R) and confirmed the high relative levels of ALDH in progenitor cells and erythroid cells. Granulocytes. which have a significantly higher background level of nonspecific fluorescence.'-' are not included in these comparisons. lnterestingly. a R-lineage (CDIO') leukemia at diagnosis and relapse has ALDH levels similar to normal R-lineage cells (Fig 4R) .
DISCUSSION
Although the concept that cellular ALDH activity may modulate sensitivity to cyclophosphamide was introduced over 20 years ago. the clinical relevance of cellular ALDH activity has only recently begun to be realized. Studies of use only. (Fig 2) . demonstrates one advantage of measuring intracellular protein levels by flow cytometry. This observation would not have been noted by immunoblotting. which reveals average levels in a population rather than levels in individual cells, and suggests that exposure of these cells to 4-hydroperoxycyclophosphamide might result in the overgrowth of the "resistant," high ALDH population.
The flow cytometric assay allowed us to demonstrate relatively higher ALDH levels in normal human lymphohematopoietic progenitor cells (CD34") and erythroid lineage cells (the latter in agreement with previously documented" elevated ALDH levels in red blood cells) than in other normal lymphohematopoietic cell types. These results represent the first direct demonstration of elevated levels of ALDH in human hematopoietic progenitor cells and are in agreement with the survival of this cell population during marrow purging with high concentrations of 4-hydroperoxycyclophosphamide. Though the CD34' cell population represents only 1% to 4% of total bone marrow mononuclear cells, 
. Examples of relative ALDH levels in progenitor cells (CD34'). B-lymphoid cells (CD22'). T-lymphoid cells (CD5'). monocytes (CD14'
). erythroid progenitors (glycophorin'), and a B-lineage leukemia (greater than 95% blasts; no cell surface labeling used) at diagnosis and relapse are shown.
stage.I4 While characterization of the cell responsible for marrow repopulation is not presently possible, earlier studies have clearly shown that cell survival after exposure to 4-hydroperoxycyclophosphamide is directly related to ALDH content in a number of human leukemia cell lines. As methods of isolating rare bone marrow cell populations continue to improve, direct measurements of ALDH enzymatic activity and its correlation to cyclophosphamide resistance are becoming feasible. Our data also suggest that intracellular ALDH levels or activity could be used as a marker of hematopoietic progenitor cells or to herald the appearance of cyclophosphamide-resistant cells in malignancies. A normal physiologic role for evaluated ALDH in hematopoietic progenitor cells has not yet been identified.
